Table 1.
Patient demographics and tumor characteristics
| Initial treatment (n = 387) | Recurrent disease (n = 50) | p value | |
|---|---|---|---|
| Age (years) (median, IQR) | 55 (46–61) | 53 (44–61) | 0.54 |
| Female gender (n, %) | 251 (65%) | 38 (76%) | 0.15 |
| Body mass index (kg/m2) (median, IQR) | 27.0 (23.4–31.8) | 24.6 (22.0–28.4) | 0.01 |
| Grade (n, %) | |||
| Well differentiated | 225 (58%) | 33 (66%) | 0.36 |
| Moderately differentiated | 93 (24%) | 12 (24%) | |
| Poorly differentiated | 69 (18%) | 5 (10%) | |
| Signet ring cell (n, %) | 19 (5%) | 0 (0%) | 0.25 |
| PCI (median, IQR) | 17 (15–19) | 18 (12–21) | 0.39 |
| Preoperative chemotherapy (n, %) | 72 (19%) | 14 (28%) | 0.13 |
Bold indicates statistically significant finding